EIKN Eikon Therapeutics, Inc. - Common Stock
$11,00
Harga · Mei 20, 2026
Fundamental per Mei 11, 2026
Rentang 52M
$8–$17
33% of range
Peringkat Analis
BUY
12 analysts
Target Harga
$30
+175% upside
P/E (TTM)
—
ROE
—
Margin Laba Bersih
—
EIKN Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu
Harga
$10.99
Kapitalisasi Pasar
—
P/E (TTM)
—
EPS (TTM)
—
Pendapatan (TTM)
—
Imbal Hasil Dividen
—
ROE
—
D/E Utang/Ekuitas
—
Rentang 52M
$8 – $17
EIKN Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda
Configure
Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS
Pendapatan & Laba Bersih
—
EPS
—
Arus Kas Bebas
—
Margin
—
Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?
Metrik
Tren 5 Tahun
EIKN
Median Rekan
Profitabilitas Margin kotor, operasional, dan bersih; ROE, ROA, ROIC
Metrik
Tren 5 Tahun
EIKN
Median Rekan
Kesehatan Keuangan Utang, likuiditas, solvabilitas — kekuatan neraca
Metrik
Tren 5 Tahun
EIKN
Median Rekan
Pertumbuhan Pertumbuhan Pendapatan, EPS, dan Laba Bersih: YoY, CAGR 3T, CAGR 5T
Metrik
Tren 5 Tahun
EIKN
Median Rekan
Efisiensi Modal Perputaran aset, perputaran persediaan, perputaran piutang
Metrik
Tren 5 Tahun
EIKN
Median Rekan
EIKN Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan
BELI
12 analis
- Beli Kuat 3 25,0%
- Beli 7 58,3%
- Tahan 1 8,3%
- Jual 0 0,0%
- Jual Kuat 1 8,3%
Target Harga 12 Bulan
4 analis · 2026-05-18
Median
$30.50
← Di bawah semua target
$10.99
Rendah
$26.00
Tinggi
$34.00
Target median
$30.50
+177,4%
Target rata-rata
$30.25
+175,1%
Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya
Kejutan Rata-rata
-0.68%
| Periode | EPS Aktual | EPS Estimasi | Kejutan |
|---|---|---|---|
| 31 Maret 2026 | $-2.46 | $-1.78 | -0.68% |
Perbandingan Sejawat Metrik utama vs rekan sektor
| Ticker | Kapitalisasi Pasar | P/E | Pendapatan YoY | Margin Bersih | ROE | Margin Kotor |
|---|---|---|---|---|---|---|
| EIKN | — | — | — | — | — | — |
| ALLO | $314M | -1.6 | -76.8% | — | -59.9% | — |
| IRWD | $550M | 22.5 | -15.7% | 8.1% | -8.5% | — |
| SLDB | $445M | -2.8 | — | — | -79.5% | — |
| GYRE | $645M | 353.0 | 10.2% | 8.5% | 11.7% | — |
| TRAX | — | — | — | — | — | — |
| CADL | $310M | -7.8 | — | — | -53.7% | — |
| CLYM | $191M | -4.5 | — | — | -34.6% | — |
| CABA | $220M | -1.0 | — | — | -115.5% | — |
| KYTX | $568M | -2.6 | — | — | -77.4% | — |
| MDXG | $1.00B | 21.2 | 20.0% | 11.6% | 20.5% | 82.6% |
Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas
Neraca 18
| Metrik | Tren | 2025 |
|---|---|---|
| Cash & Equivalents | $105M | |
| Short-term Investments | $231M | |
| Prepaid Expense | $13M | |
| Current Assets | $349M | |
| PP&E (Net) | $143M | |
| PP&E (Gross) | $186M | |
| Accum. Depreciation | $43M | |
| Other Non-current Assets | $4M | |
| Total Assets | $595M | |
| Accounts Payable | $681.0K | |
| Current Liabilities | $55M | |
| Capital Leases | $247M | |
| Other Non-current Liabilities | $10M | |
| Total Liabilities | $312M | |
| Retained Earnings | $-921M | |
| Stockholders' Equity | $-879M | |
| Liabilities + Equity | $595M | |
| Shares Outstanding | 3,068,490 |
Laporan Laba Rugi 10
| Metrik | Tren | Q1 2026 |
|---|---|---|
| R&D Expense | $70M | |
| SG&A Expense | $17M | |
| Operating Expenses | $87M | |
| Operating Income | $-87M | |
| Net Income | $-83M | |
| EPS (Basic) | $-2.46 | |
| EPS (Diluted) | $-2.46 | |
| Shares (Basic) | 33,700,550 | |
| Shares (Diluted) | 33,700,550 | |
| EBITDA | $-87M |
Neraca 19
| Metrik | Tren | Q1 2026 |
|---|---|---|
| Cash & Equivalents | $161M | |
| Short-term Investments | $351M | |
| Prepaid Expense | $17M | |
| Current Assets | $530M | |
| PP&E (Net) | $138M | |
| PP&E (Gross) | $186M | |
| Accum. Depreciation | $48M | |
| Other Non-current Assets | $556.0K | |
| Total Assets | $851M | |
| Accounts Payable | $6M | |
| Current Liabilities | $45M | |
| Capital Leases | $245M | |
| Other Non-current Liabilities | $10M | |
| Total Liabilities | $300M | |
| Common Stock | $5.0K | |
| Retained Earnings | $-1.00B | |
| Stockholders' Equity | $551M | |
| Liabilities + Equity | $851M | |
| Shares Outstanding | 54,138,555 |
Arus Kas 8
| Metrik | Tren | Q1 2026 |
|---|---|---|
| Stock-based Comp | $3M | |
| Operating Cash Flow | $-90M | |
| CapEx | $262.0K | |
| Investing Cash Flow | $-203M | |
| Stock Issued | $277.0K | |
| Net Stock Activity | $277.0K | |
| Financing Cash Flow | $349M | |
| Free Cash Flow | $-90M |
Profitabilitas 5
| Metrik | Tren | Q1 2026 |
|---|---|---|
| Operating Margin | -1994.0% | |
| Net Margin | -1894.0% | |
| EBITDA Margin | -1994.0% | |
| ROA | -19.5% | |
| ROE | -30.1% |
Likuiditas & Solvabilitas 2
| Metrik | Tren | Q1 2026 |
|---|---|---|
| Current Ratio | 11.8 | |
| Quick Ratio | 11.4 |
Efisiensi 1
| Metrik | Tren | Q1 2026 |
|---|---|---|
| Asset Turnover | 0.0 |
Valuasi (TTM) 5
| Metrik | Tren | Q1 2026 |
|---|---|---|
| Market Cap | $573M | |
| P/B | 1.0 | |
| P / Tangible Book | 1.0 | |
| P / Cash Flow | -6.4 | |
| P / FCF | -6.4 |
Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir
Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap
📊
Pilih metrik yang penting bagi Anda — klik ➕ di sebelah baris mana pun di Fundamental Lengkap di atas.
Pilihan Anda disimpan dan mengikuti Anda di semua ticker.